UBS Group »

Adma Biologics shares owned by UBS Group

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 498k 4.52
2023-09-30 $817k 228k 3.58
2023-06-30 $1.0M 284k 3.69
2023-03-31 $1.3M 384k 3.31
2022-12-31 $2.1M 543k 3.88
2022-09-30 $154k 63k 2.43
2022-03-31 $21k 11k 1.84
2021-09-30 $0 18k 0.00
2021-06-30 $10k 5.0k 2.05
2021-03-31 $36k 20k 1.77
2020-12-31 $43k 22k 1.97
2020-09-30 $10k 4.2k 2.50
2020-06-30 $109k 37k 2.93
2020-03-31 $100k 35k 2.87
2019-12-31 $231k 58k 4.01
2019-09-30 $286k 64k 4.45
2019-06-30 $19k 5.0k 3.80
2019-03-31 $5.0k 1.4k 3.51
2018-12-31 $838k 351k 2.39
2018-09-30 $40k 6.6k 6.00
2018-06-30 $30k 6.7k 4.45
2018-03-31 $14k 3.1k 4.56
2017-09-30 $10k 3.4k 2.94
2016-06-30 $1.0k 160 6.25
2016-03-31 $26k 3.2k 8.14